Press release
Global Trastuzumab Biosimilar Market is Expected to Grow at Rapid Pace With Strong Presence of Major Players such as Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc
Trastuzumab is marketed under the trade/brand name of Herceptin. It is developed by F. Hoffmann-La Roche AG and was approved by U.S Food Drug Administration (FDA) in 1998 and by European Medicines Agency in 2000. Trastuzumab is a recombinant DNA-derived humanized monoclonal antibody that binds to human epidermal growth factor receptor 2 (HER2). It is also approved for the treatment of HER2 positive breast cancer as well as it is also approved for the treatment of metastatic breast cancer and gastric cancer. Patent of Herceptin expired in Europe in 2014, in Asia in 2017, and in the U.S. the patent will expire in 2019.
Samsung Bioepis announced the launch of first biosimilar for trastuzumab i.e Ontruzant in Europe on November 2017, thus entry of biosimilar into the market have boosted the growth of trastuzumab biosimilar market.
Request for ToC/Proposal: https://bit.ly/2XhOLc1
The trastuzumab biosimilar market is fragmented/consolidated with presence of many/few players that operates in local as well as international market.
Global trastuzumab biosimilar Market reports cover prominent players like Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc., AryoGen Pharmed, Samsung BioepisCo., Ltd., and Merck & Co.
Curious about this latest version of report?
Obtain Report Details @ https://bit.ly/2XhOLc1
Market Segments
• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Application
o Breast Cancer
o Gastric Cancer
o Other
• Global Trastuzumab Biosimilar Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Distribution Channel
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy
o Other Direct Distribution Channels
Why should buy this report:
To receive a comprehensive analysis of the prospects for global trastuzumab biosimilar market
To receive industry overview and future trends trastuzumab biosimilar market
To analyze the trastuzumab biosimilar market drivers and challenges
To get information on trastuzumab biosimilar market size and forecast
To get details on trastuzumab biosimilar clinical trial/pipeline analysis
Originator drug historic revenue
Originator drug key news/industry activities
Major Mergers & Acquisition in trastuzumab biosimilar industry
For More Information @ https://bit.ly/2XhOLc1
Mr. John Smith
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ https://bit.ly/2EgGlWR
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Trastuzumab Biosimilar Market is Expected to Grow at Rapid Pace With Strong Presence of Major Players such as Amgen Inc., Biocon Limited, Mylan Inc., BioXpress Therapeutics SA, Celltrion, Teva Pharmaceutical Industries Ltd., Apotex Inc., Pfizer Inc here
News-ID: 1785737 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Virtualized Evolved Packet Core Market Know the Scope and Trends
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Virtualized Evolved Packet Core Market- (By Offerings (Solutions(Virtualized Packet Gateway, Virtualized Mobility Management Entity (vMME), Policy and Charging Rules Function (PCRF)), Services (Consulting and Advisory Services, System Integration and Deployment Services, Maintenance and Support Services)), Deployment Mode (On-Premises, Cloud-based), By Network Type (LTE, 5G), By End-User (Telecommunication Service Providers, (Mobile Network Operators (MNOs), Virtual Network…
Medical Reference Apps Market to Record an Exponential CAGR by 2030
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Medical Reference Apps Market- by Type (Monthly and Annual Subscriptions), Application (Drug Information, Medical Conditions & Symptoms, Medical News & Development, Articles & Educational Reference Materials, and Other Applications), Types of Platform (Android and iOS), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Request for Sample Pages: https://www.insightaceanalytic.com/request-sample/1031
According to the latest research by InsightAce…
AI in Livestock Farming Market 2023 | Detailed Analysis Report to 2030
According to the latest research by InsightAce Analytic, the global Artificial Intelligence in Livestock Farming market is expected to register a CAGR of 26.2% during a forecast period of 2022-2030.
Download Free Report Brochure: https://www.insightaceanalytic.com/request-sample/1323
AI is just a reflection of human intelligence that employs algorithms to carry out a variety of chores that farmers previously did. Software, apps, and sensors powered by the Internet of Things are the main elements…
IoT for Fisheries and Aquaculture Market Exclusive Report to 2030
According to the latest research by InsightAce Analytic, the global IoT for Fisheries and Aquaculture market is valued at US$ 415.37 Million in 2021, and it is expected to reach US$ 1,232.32 Million by 2030, with a CAGR of 13.2% during a forecast period of 2022-2030.
Get Free Sample Copy of the Report :
https://www.insightaceanalytic.com/request-sample/1303
IoT has already demonstrated a wide range of application sectors in recent years. Internet of Things…
More Releases for Trastuzumab
Trastuzumab Biosimilars Market Insights, Competitive Research And Key Segments R …
The global trastuzumab biosimilars market size is expected to grow from $2.08 billion in 2021 to $2.64 billion in 2022 at a compound annual growth rate (CAGR) of 27.1%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the…
Trastuzumab Biosimilar Market 2022 | Detailed Report
According to Market Study Report, Trastuzumab Biosimilar Market provides a comprehensive analysis of the Trastuzumab Biosimilar Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5511273
The report provides a comprehensive analysis of company profiles listed below:
- Amgen Inc.
- Pfizer Inc
- Samsung Bioepis
-…
Trastuzumab Biosimilar Market Technology, Recent Trends, Future Growth Analysis …
PSP (progressive supranuclear palsy) is a rare progressive disorder that can affect balance, mobility, vision, speech, and swallowing. It's caused by an increase in the number of damaged brain cells over time. According to the PSP Association, there are around 4,000 persons in the UK who have PSP. The global Progressive Supranuclear Palsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020,…
Trastuzumab Biosimilars Market 2021 - Industry Size, Share, Growth, Trends and G …
New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
The global trastuzumab biosimilars market is expected to grow from $1.22 billion in 2020 to $1.4 billion in 2021 at a compound annual growth rate (CAGR) of 14.8%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering…
Global Trastuzumab Market:Competitive Landscape & Key Player Tactics| Genentech …
LOS ANGELES, United States: QY Research as of late produced a research report titled, “Global Trastuzumab Market Research Report 2020". The research report speak about the potential development openings that exist in the worldwide market. The report is broken down on the basis of research procedures procured from historical and forecast information. The global Trastuzumab market is relied upon to develop generously and flourish as far as volume and incentive…
Global Trastuzumab Market Research Report 2017
In this report, the global Trastuzumab market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Trastuzumab in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
For…
